Pharma & Biotech

Biotechnology firm VolitionRX Ltd. enters a critical period marked by two significant corporate developments: the release of fresh clinical study...

Hercules Capital, a leading specialty finance company, has significantly increased its exposure to the life sciences sector through two major...

While Viking Therapeutics shares continue to navigate a challenging correction, having shed approximately 15% over the past month, a recent...

ImmunityBio has entered 2026 with significant momentum, propelled by a confluence of fresh clinical data, key regulatory communications, and international...

The independent public listing of Tübingen-based mRNA pioneer CureVac has been formally terminated. The company's shares have been delisted from...

Shares of AnaptysBio are trading marginally lower than the previous session's close. The company's valuation is currently tethered to a...

Alexandria Real Estate Equities, a leading real estate investment trust specializing in life science properties, has released its financial results...

Viking Therapeutics has filed a mandatory disclosure with the U.S. Securities and Exchange Commission (SEC) detailing the compensation package for...

A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...

The Danish pharmaceutical giant Novo Nordisk is navigating a complex period marked by operational restructuring and legal scrutiny. As the...